Carty N J, Carter C, Royle G T, Johnson C D
University Surgical Unit, Royal South Hants Hospital, Southampton.
Ann R Coll Surg Engl. 1995 May;77(3):163-7.
The advent of mammographic breast screening has increased the detection of ductal carcinoma in situ (DCIS), which now accounts for 15-20% of all breast cancer. While symptomatic DCIS has been treated satisfactorily by mastectomy, this may be an overtreatment of smaller screen-detected lesions. Although local excision, with or without radiotherapy, is associated with a significant risk of local recurrence of DCIS or invasive cancer, salvage surgery is usually successful. The long-term breast-specific mortality rate of treatment by mastectomy and local excision are similar. Whereas mastectomy is still appropriate for women with lesions > 30 mm in diameter or centrally placed and for those women who demand the best possible disease-free survival, local surgery should otherwise be considered.
乳腺钼靶筛查的出现增加了导管原位癌(DCIS)的检出率,目前DCIS占所有乳腺癌的15% - 20%。虽然有症状的DCIS通过乳房切除术得到了满意的治疗,但对于较小的筛查发现的病变,这可能属于过度治疗。尽管局部切除,无论是否联合放疗,都与DCIS或浸润性癌局部复发的显著风险相关,但挽救性手术通常是成功的。乳房切除术和局部切除治疗的长期乳腺特异性死亡率相似。对于直径>30mm或位于中央的病变的女性以及那些要求获得最佳无病生存率的女性,乳房切除术仍然是合适的,否则应考虑局部手术。